Neogen (NEOG) Land & Improvements (2011 - 2025)
Neogen's (NEOG) quarterly Land & Improvements came in at $10.8 million in Q2 2025, up 3.04% year-on-year from $10.5 million in Q2 2024, and up 3.04% quarter-over-quarter from $10.5 million in Q2 2024.
Neogen (NEOG) Land & Improvements (2011 - 2025) Analysis & Trends
Neogen's Land & Improvements history runs 15 years deep, the most recent figure standing at $10.8 million for Q2 2025.
- On a quarterly basis, Land & Improvements rose 3.04% year-over-year to $10.8 million in Q2 2025; TTM through May 2025 was $10.8 million, a 3.04% increase from a year earlier, with the FY2025 full-year figure at $10.8 million, up 3.04% from the prior year.
- Land & Improvements improved to $10.8 million in Q2 2025 per NEOG's latest filing, from $10.5 million in the prior quarter.
- Across five years, Land & Improvements topped out at $10.8 million in Q2 2025 and bottomed at $7.8 million in Q2 2021.
- The 5-year median for Land & Improvements is $10.2 million (2023), against an average of $9.8 million.
- Across the five-year window, Land & Improvements soared 42.65% in 2021 and climbed 2.82% in 2024, its largest moves.
- Year by year, Land & Improvements stood at $7.8 million in 2021, then grew by 21.87% to $9.5 million in 2022, then increased by 7.63% to $10.2 million in 2023, then gained by 2.82% to $10.5 million in 2024, then grew by 3.04% to $10.8 million in 2025.
- Per Business Quant, the three latest NEOG Land & Improvements figures stand at $10.8 million (Q2 2025), $10.5 million (Q2 2024), and $10.2 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.80 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 188.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 10.82 Mn |
| May 31, 2024 | 10.50 Mn |
| May 31, 2023 | 10.21 Mn |
| May 31, 2022 | 9.49 Mn |
| May 31, 2021 | 7.78 Mn |
| May 31, 2020 | 5.46 Mn |
| May 31, 2019 | 5.32 Mn |
| May 31, 2018 | 4.73 Mn |
| May 31, 2017 | 3.09 Mn |
| May 31, 2016 | 2.66 Mn |
| May 31, 2015 | 2.30 Mn |
| May 31, 2014 | 1.88 Mn |
| May 31, 2013 | 1.67 Mn |
| May 31, 2012 | 1.44 Mn |
| May 31, 2011 | 1.20 Mn |